Search

everythinglearnresearchcommunity

for

Search:↓

The document discusses various eye conditions and their treatments, including a rare eye cancer in a baby, vision loss from a cancer drug, cataracts from a baldness treatment, a rare skin disorder, and a specific type of eye disease diagnosed with a special imaging technique.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

The research found genetic differences in identical twins that could explain why one twin has a disease while the other does not.

Scalp areas that look normal in people with hair loss may still show signs of disease under a microscope.

Sebaceous glands are involved in various skin disorders, some treatable with medications like finasteride and minoxidil.

Botulinum toxin has potential for treating various skin conditions and improving wound healing.

The document concludes that various skin conditions have specific treatments, ranging from antihistamines for urticaria to surgery and medication for tumors and chronic skin diseases.

People distressed by minor skin changes should consult dermatologists with cosmetic expertise, and a public Cosmetic Dermatology Service with mental health support is recommended.

Both induced and spontaneous AA lymphocytes can cause alopecia areata in mice.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Dupilumab can cause rare side effects like a rash on the face and neck.

A mutation in the hairless gene speeds up severe itchy skin in mice on a special diet.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Sex hormones likely don't affect atopic dermatitis in adolescents and adults.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Mineral levels in hair don't significantly affect the severity of atopic dermatitis in children.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Bleach baths with 0.005% hypochlorite help manage atopic dermatitis by affecting skin cells and reducing itchiness.

Autoimmune and metabolic issues are linked, and treating one may worsen another.

STAT3 signaling is important for healthy skin and hair follicles, and its disruption can lead to skin conditions like atopic dermatitis.

A baby was diagnosed with IFAP syndrome due to a new genetic mutation, showing severe skin and developmental issues.

Different types of atopic dermatitis were linked to specific genetic and immune changes, suggesting that severe cases might need stronger immune-targeting treatments.

TSLP affects atopic dermatitis by increasing sebum and reducing fat through IL-4/IL-13 signaling.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

More precise, personalized therapies are needed for autoimmune diseases.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

The sebaceous gland has more roles than just producing sebum and contributing to acne, and new research could lead to better skin disease treatments.

High-frequency ultrasonography is a useful but underused tool in dermatology for assessing skin cancers, monitoring diseases, and evaluating treatments.